Biosyent Inc. (RX.V) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · Canada · ISIN CA0906901081
Biosyent Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 35.03 m CAD | 43.05 m CAD |
| Gross profit | 27.86 m CAD | 32.96 m CAD |
| Operating income | 9.06 m CAD | 11.31 m CAD |
| EBIT | 9.84 m CAD | 12.08 m CAD |
| Net income | 7.27 m CAD | 9.01 m CAD |
| Diluted EPS – continuing operations | 0.64 CAD | 0.80 CAD |
Full history since 1997, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Biosyent Inc.
BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. BioSyent Inc. was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. The company was incorporated in 2006 and is headquartered in Mississauga, Canada.
More stocks
- Thai Nakarin Hospital Public Company Limited (TNH.BK)
- STONERIDGE INC (SRI)
- SBB Tech Co Ltd (389500.KQ)
- James River Group Holdings, Inc. (JRVR)
- IntoCell, Inc. (287840.KQ)
- Cenra Inc. (3716.TW)
- Orilina Properties REIC S.A. (ORILINA.AT)
- EOI Holding (3717.TW)
- Torimbia Socimi S.A. (YTRM.MC)
- Alpha Technology Group Limited Ordinary Shares (ATGL)
- Bjorn Borg AB (BORG.ST)
- Carnaby Resources Ltd (CNB.AX)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.